Biocryst Pharmaceuticals buy HC Wainwright
Start price
04.08.23
/
50%
€6.90
Target price
04.08.24
€27.22
Performance (%)
-7.45%
End price
05.08.24
€6.39
Summary
This prediction ended on 05.08.24 with a price of €6.39. With a performance of -7.45%, the BUY prediction for Biocryst Pharmaceuticals by HC_Wainwright closed slightly in the red. HC_Wainwright has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | 5.823% | 5.823% | -33.820% |
| iShares Core DAX® | 0,46 % | -1,53 % | 9,99 % |
| iShares Nasdaq 100 | -1,79 % | -5,38 % | -0,88 % |
| iShares Nikkei 225® | 5,12 % | 8,05 % | 30,03 % |
| iShares S&P 500 | -1,76 % | -3,82 % | -0,21 % |
Comments by HC_Wainwright for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten
Current prediction by HC_Wainwright for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.80
25.02.25
25.02.25
€28.57
25.02.26
25.02.26
-25.78%
09:32
09:32
Stopped prediction by HC_Wainwright for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.43
15.12.25
15.12.25
€27.26
15.12.26
15.12.26
-9.92%
09:32
09:32
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€9.65
06.05.25
06.05.25
€26.56
06.05.26
06.05.26
-39.98%
09:32
09:32
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.20
06.08.24
06.08.24
€27.50
06.08.25
06.08.25
1.14%
07.08.25
07.08.25
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.98
07.05.24
07.05.24
€27.83
07.05.25
07.05.25
78.99%
08.05.25
08.05.25

